Cleared Special

EKF- DIAGNOSTIC HEMO_CONTROL HEMOGLOBIN MEASUREMENT SYSTEM; EKF-DIAGNOSTIC HEMOGLOBIN MICROCUVETTES (MODIFIED CURVETTE W

K110393 · Ekf Diagnostic GmbH · Hematology
Mar 2011
Decision
21d
Days
Class 2
Risk

About This 510(k) Submission

K110393 is an FDA 510(k) clearance for the EKF- DIAGNOSTIC HEMO_CONTROL HEMOGLOBIN MEASUREMENT SYSTEM; EKF-DIAGNOSTIC HEMOGLOBIN MICROCUVETTES (MODIFIED CURVETTE W, a System, Hemoglobin, Automated (Class II — Special Controls, product code GKR), submitted by Ekf Diagnostic GmbH (Egale, US). The FDA issued a Cleared decision on March 4, 2011, 21 days after receiving the submission on February 11, 2011. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5620.

Submission Details

510(k) Number K110393 FDA.gov
FDA Decision Cleared SESE
Date Received February 11, 2011
Decision Date March 04, 2011
Days to Decision 21 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GKR — System, Hemoglobin, Automated
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.5620